GLP-1 Market
LLY $1166.51 ▼ -1.4% NVO $38.06 ▼ -1.3% PFE $28.37 ▼ -0.1% VKTX $26.65 ▼ -6.0% KLRA $10.77 ▼ -4.9% GPCR $22.31 ▼ -6.7% RHHBY $53.77 ▼ -0.6%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Hydrochlorothiazide

Company
Baylor Research Institute
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
23 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

23 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Find a Clinical Trial Near Me

See recruiting studies for Hydrochlorothiazide and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02817360

    NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

    Not yet reported Martin Huelsmann 2400 participants Est. completion 2026-12 21 sites
    Type 2 diabetes Other conditions: Heart Diseases
    View official trial listing →
  • Recruiting NCT NCT03476551

    Bariatric Surgery and Pharmacokinetics of Hydrochlorothiazide

    Norwegian University of Science and Technology 12 participants Est. completion 2026-10 1 site
    Other conditions: Obesity, Morbid
    View official trial listing →
  • Recruiting NCT NCT03511118

    Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

    Duke University 1600 participants Est. completion 2028-07-31 22 sites
    Other conditions: Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI
    View official trial listing →
  • Recruiting NCT NCT04191681

    Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study

    Not yet reported The Cleveland Clinic 50 participants Est. completion 2022-12 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT04662723

    Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

    Not yet reported Fondazione Schena 878 participants Est. completion 2028-12-31 2 sites
    Other conditions: Glomerulonephritis, Immunoglobulin A Nephropathy
    View official trial listing →
  • Recruiting NCT NCT04934228

    Mitigating the Pro-inflammatory Phenotype of Obesity

    Not yet reported University of Kansas Medical Center 60 participants Est. completion 2027-08-01 1 site Stand-alone
    Other conditions: Blood Pressure, Diabetes, Obesity, Insulin Resistance, Diuretics Drug Reactions, Sympathetic Nerve Activity
    View official trial listing →
  • Recruiting NCT NCT04977180

    Cardioprotection in AML

    Not yet reported University of Virginia 70 participants Est. completion 2028-09 1 site Stand-alone
    Other conditions: AML, Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT05373264

    HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life

    Not yet reported University Medical Center Groningen 300 participants Est. completion 2031-07 25 sites
    Other conditions: ADPKD
    View official trial listing →
  • Recruiting NCT NCT05413057

    An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

    Boryung Pharmaceutical Co., Ltd 20000 participants Est. completion 2026-06 1 site
    Other conditions: Hypertension,Essential
    View official trial listing →
  • Recruiting NCT NCT05498675

    Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

    Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
    Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
    View official trial listing →
  • Recruiting NCT NCT05530655

    A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer

    Not yet reported University of Rochester 30 participants Est. completion 2028-01-01 1 site Stand-alone
    Other conditions: Prostate Cancer, Radiation Toxicity, Urinary Complication
    View official trial listing →
  • Recruiting NCT NCT05582837

    Treatment of Meniere's Disease With Migraine Medications

    Not yet reported University of California, Irvine 40 participants Est. completion 2027-12-30 1 site
    Other conditions: Ménière
    View official trial listing →
  • Recruiting NCT NCT05963568

    Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)

    Not yet reported Northern California Institute of Research and Education 1000 participants Est. completion 2029-02-01 4 sites Stand-alone
    Cardiovascular disease Other conditions: Medication Adherence
    View official trial listing →
  • Recruiting NCT NCT06111885

    Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention

    Not yet reported Insel Gruppe AG, University Hospital Bern 99 participants Est. completion 2027-06-30 1 site
    Other conditions: Kidney Stone
    View official trial listing →
  • Recruiting NCT NCT06377449

    Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients

    Not yet reported Saint Petersburg State University, Russia 186 participants Est. completion 2026-01-01 1 site
    Other conditions: Ischemic Heart Disease, Aortic Stenosis, Severe, Aortic Insufficiency, Mitral Stenosis, Mitral Insufficiency, Mitral Stenosis With Insufficiency, Tricuspid Insufficiency, Ascending Aortic Aneurysm
    View official trial listing →
  • Recruiting NCT NCT06841692

    Diuretic Testing in Chronic Kidney Disease

    Not yet reported Erasmus Medical Center 86 participants Est. completion 2029-10-31 1 site Stand-alone
    Other conditions: Kidney Disease, Chronic
    View official trial listing →
  • Recruiting NCT NCT07008365

    The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure

    Not yet reported Instituto de Investigación Sanitaria Aragón 168 participants Est. completion 2026-12-31 2 sites Stand-alone
    Heart failure Other conditions: Intraabdominal Hypertension, Cardio-Renal Syndrome
    View official trial listing →
  • Recruiting NCT NCT07020104

    The Role of Skin Sodium Accumulation in Chronic Kidney Disease

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 60 participants Est. completion 2039-12-01 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Recruiting NCT NCT07458880

    Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control

    Not yet reported The University of Hong Kong 140 participants Est. completion 2030-06-30 4 sites
    Other conditions: Intracerebral Hemorrhage
    View official trial listing →
  • Recruiting NCT NCT07513883

    The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.

    Not yet reported Ziekenhuis Oost-Limburg 100 participants Est. completion 2028-12 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT07594535

    The Effect Of Lisinopril On Polycythemia

    Not yet reported Mayo Clinic 30 participants Est. completion 2029-07-01 2 sites Stand-alone
    Other conditions: Polycythemia
    View official trial listing →
  • Recruiting NCT NCT07683585

    Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention

    Not yet reported National Medical Research Center for Therapy and Preventive Medicine 207 participants Est. completion 2026-09 1 site
    Other conditions: Hypertension, Coronary Arterial Disease, Percutaneous Coronary Intervention
    View official trial listing →
  • Recruiting NCT NCT07685938

    Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

    Not yet reported UNC Lineberger Comprehensive Cancer Center 60 participants Est. completion 2029-02 1 site Stand-alone
    Other conditions: Chest Wall Tumor, Breast Cancer, Lung Cancer, Esophageal Cancer, Mediastinal Cancers, Spine Metastases, Spinal Tumor, Thoracic Cancer, Thoracic Neoplasms
    View official trial listing →
  • Completed NCT NCT00000525

    Diuretics, Hypertension, and Arrhythmias Clinical Trial

    Not yet reported University of California, San Francisco 233 participants
    Cardiovascular diseaseSubstance use disorder Other conditions: Heart Arrest, Heart Diseases, Hypertension
    View official trial listing →
  • Completed NCT NCT00000542

    Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2002-03
    Cardiovascular diseaseHeart failure Other conditions: Coronary Disease, Diabetes Mellitus, Heart Diseases, Hypercholesterolemia, Hypertension, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00000620

    Action to Control Cardiovascular Risk in Diabetes (ACCORD)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 10251 participants Est. completion 2012-12 7 sites
    Cardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00005520

    Genetic Epidemiology of Responses to Antihypertensives

    Mayo Clinic 1200 participants Est. completion 2008-01 1 site
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension
    View official trial listing →
  • Completed NCT NCT00006294

    Genetics of Hypertension Associated Treatments (GenHAT)

    Donna Arnett, 257-5678 37939 participants Est. completion 2005-08 1 site
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00092209

    Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)

    Not yet reported Organon and Co 840 participants Est. completion 2002-11
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00095394

    Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension

    Not yet reported Bristol-Myers Squibb 645 participants Est. completion 2005-05 269 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00095550

    Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension

    Not yet reported Bristol-Myers Squibb 496 participants Est. completion 2005-06 128 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00108082

    The CLEVER Study - Coreg And Left Ventricular Mass Regression

    Not yet reported GlaxoSmithKline 287 participants Est. completion 2008-08 78 sites Stand-alone
    Other conditions: Hypertrophy, Left Ventricular
    View official trial listing →
  • Completed NCT NCT00110422

    Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome

    Not yet reported Bristol-Myers Squibb 400 participants Est. completion 2007-02 25 sites
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00123903

    COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria

    Not yet reported GlaxoSmithKline 1220 participants Est. completion 2006-05 94 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT00133185

    A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

    Not yet reported Boehringer Ingelheim 31 participants Est. completion 2005-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00139698

    Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension

    Not yet reported Pfizer 410 participants Est. completion 2006-07 32 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00142584

    Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension

    Not yet reported Mylan Bertek Pharmaceuticals 336 participants Est. completion 2008-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00144222

    Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy

    Not yet reported Boehringer Ingelheim 218 participants Est. completion 2005-08 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00146341

    Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg

    Not yet reported Boehringer Ingelheim 345 participants Est. completion 2006-09 9 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00151138

    Cognitive/Cerebrovascular Consequences of HTN Treatment

    Not yet reported University of Pittsburgh 50 participants Est. completion 2007-05 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00157963

    Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)

    Not yet reported Organon and Co 174 participants Est. completion 2006-02-08
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00160160

    Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

    Not yet reported Solvay Pharmaceuticals 440 participants 63 sites
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00168779

    Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension

    Not yet reported Boehringer Ingelheim 1185 participants Est. completion 2006-07 113 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00170937

    A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome

    Not yet reported Novartis 507 participants 1 site
    Metabolic syndrome Other conditions: HYPERTENSION, PRE-HYPERTENSION
    View official trial listing →
  • Terminated NCT NCT00170950

    Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension

    Not yet reported Novartis 11506 participants Est. completion 2008-05 5 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00170989

    Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone

    Not yet reported Novartis 2714 participants Est. completion 2005-07 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171054

    Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension

    Not yet reported Novartis 125 participants Est. completion 2007-10 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171067

    VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria

    Not yet reported Novartis 134 participants Est. completion 2007-05 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171132

    VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women

    Not yet reported Novartis 64 participants Est. completion 2007-08 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171405

    A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg

    Not yet reported Novartis 250 participants Est. completion 2006-02 10 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171535

    Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

    Not yet reported Novartis 130 participants Est. completion 2005-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171561

    Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.

    Not yet reported Novartis 144 participants Est. completion 2006-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00171600

    Antialbuminuric Effects of Valsartan and Lisinopril

    Not yet reported Novartis 54 participants Est. completion 2007-01 1 site
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171782

    Hypertension and Cardiovascular Risk Factors

    Not yet reported Novartis 76 participants Est. completion 2004-12
    Other conditions: HYPERTENSION
    View official trial listing →
  • Completed NCT NCT00185068

    An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

    Not yet reported Daiichi Sankyo 110 participants Est. completion 2004-10 16 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00185120

    Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

    Not yet reported Daiichi Sankyo 152 participants Est. completion 2006-09 20 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00185172

    Olmesartan in Essential Hypertension

    Not yet reported Sankyo Pharma Gmbh 2333 participants Est. completion 2005-06 8 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00185185

    Olmesartan Medoxomil in Atherosclerosis

    Not yet reported Sankyo Pharma Gmbh 165 participants Est. completion 2006-02 1 site Stand-alone
    Cardiovascular disease Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00219024

    Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.

    Not yet reported Novartis 2775 participants Est. completion 2005-06 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00219037

    Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension

    Not yet reported Novartis 1955 participants Est. completion 2005-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00219050

    A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension

    Not yet reported Novartis 180 participants Est. completion 2005-11 4 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00219063

    A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.

    Not yet reported Novartis 844 participants Est. completion 2006-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00219102

    A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients

    Not yet reported Novartis 336 participants Est. completion 2007-05 7 sites
    Other conditions: Hypertension, Diabetes
    View official trial listing →
  • Completed NCT NCT00219115

    A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg

    Not yet reported Novartis 493 participants Est. completion 2006-03 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00219167

    A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure

    Not yet reported Novartis 355 participants Est. completion 2006-02 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00220233

    Olmesartan as an add-on to Amlodipine in Hypertension

    Not yet reported Sankyo Pharma Gmbh 632 participants Est. completion 2007-08 5 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00223717

    Treatment of Supine Hypertension in Autonomic Failure

    Not yet reported Vanderbilt University 152 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00224549

    PHARES Study: Management of Resistant Hypertension

    Not yet reported Assistance Publique - Hôpitaux de Paris 180 participants Est. completion 2009-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00231803

    The Canadian Prevention of Renal and Cardiovascular Endpoints Trial

    Not yet reported Brendan Barrett 474 participants Est. completion 2008-06 5 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00232882

    Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.

    Not yet reported Institut de Recherches Cliniques de Montreal 86 participants Est. completion 2006-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00234858

    Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)

    Not yet reported Abbott 280 participants
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00239369

    Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5

    Not yet reported Boehringer Ingelheim 713 participants Est. completion 2006-08 84 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00240448

    A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients

    Not yet reported Boehringer Ingelheim 1109 participants 100 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00240474

    A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)

    Not yet reported Boehringer Ingelheim 1000 participants Est. completion 2004-03 73 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00241124

    Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes

    Not yet reported Novartis 1099 participants Est. completion 2005-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00241904

    Reducing Total Cardiovascular Risk in an Urban Community

    Not yet reported Johns Hopkins University 525 participants Est. completion 2010-05 1 site
    Cardiovascular disease Other conditions: Heart Diseases, Coronary Disease, Diabetes Mellitus, Atherosclerosis, Cerebral Arteriosclerosis, Hypertension
    View official trial listing →
  • Completed NCT NCT00246519

    Pharmacogenomic Evaluation of Antihypertensive Responses

    Not yet reported University of Florida 1701 participants Est. completion 2010-12 3 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00247910

    Behavioural Treatment of Hypertension

    Not yet reported University of British Columbia 150 participants Est. completion 2006-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00257491

    Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

    Not yet reported Boehringer Ingelheim 29 participants Est. completion 2006-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00264212

    AMISH : Aprovel for Management of Isolated Systolic Hypertension

    Not yet reported Sanofi 436 participants 8 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00267943

    Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive Patients

    Not yet reported Boehringer Ingelheim 639 participants Est. completion 2007-01 78 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00273299

    Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension

    Not yet reported Novartis 607 participants Est. completion 2006-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00277472

    Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

    Not yet reported Novartis 300 participants 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT00280215

    Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

    Not yet reported Mayo Clinic Est. completion 2011-12
    Other conditions: Hyperoxaluria
    View official trial listing →
  • Completed NCT NCT00280540

    Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

    Not yet reported Novartis 648 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00282178

    Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

    Not yet reported Umeå University 26 participants Est. completion 2006-04 1 site
    Other conditions: Hypertension, Obesity
    View official trial listing →
  • Completed NCT NCT00283686

    HALT Progression of Polycystic Kidney Disease Study A

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 558 participants Est. completion 2014-06 7 sites
    Other conditions: Kidney, Polycystic
    View official trial listing →
  • Completed NCT NCT00289887

    Obese Hypertension Study (0954-315)

    Not yet reported Organon and Co 261 participants Est. completion 2007-03 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00292162

    Curing Atrial Fibrillation in Heart Failure

    Not yet reported NHS Greater Glasgow and Clyde 41 participants Est. completion 2009-07 1 site
    Heart failure Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00294710

    A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine

    Not yet reported Novartis 976 participants Est. completion 2006-07 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00295542

    Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy

    Not yet reported University of Vigo 3344 participants Est. completion 2009-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00304226

    Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

    Not yet reported Novartis 1288 participants Est. completion 2007-01 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00307060

    MK0954A-264 Filter Study (0954A-264)(COMPLETED)

    Not yet reported Organon and Co 274 participants Est. completion 2005-06-02
    Other conditions: Mild to Severe Hypertension
    View official trial listing →
  • Completed NCT NCT00311155

    Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

    Not yet reported Sankyo Pharma Gmbh 694 participants Est. completion 2008-04 79 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00311740

    A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)

    Not yet reported Novartis 582 participants Est. completion 2006-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00311870

    Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy

    Not yet reported Steno Diabetes Center Copenhagen 52 participants Est. completion 1999-04 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00327145

    A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy

    Not yet reported Novartis 894 participants Est. completion 2007-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00327587

    8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

    Not yet reported Novartis 2279 participants Est. completion 2007-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00335673

    I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients

    Not yet reported Sanofi 1630 participants Est. completion 2006-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00337298

    The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes

    Not yet reported University of Aarhus 25 participants Est. completion 2009-02 1 site Stand-alone
    Other conditions: Type 1 Diabetes, Diabetic Retinopathy, Eye Diseases, Diabetes Complications
    View official trial listing →
  • Completed NCT NCT00338936

    Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)

    Not yet reported Novartis 362 participants Est. completion 2007-09
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00347360

    The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial

    Not yet reported GlaxoSmithKline 654 participants Est. completion 2008-04 151 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00354991

    Hyzaar Asia HEAALTH (0954A-950)

    Not yet reported Merck Sharp & Dohme LLC 437 participants Est. completion 2007-04-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00355589

    Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

    Not yet reported Pfizer Est. completion 2007-03 60 sites
    Other conditions: Hypertension, Blood Pressure, High
    View official trial listing →
  • Completed NCT NCT00360178

    Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

    Not yet reported Novartis 198 participants Est. completion 2006-12 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00362037

    I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy

    Not yet reported Sanofi 281 participants Est. completion 2008-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00362258

    I PREVENT - Irbesartan In Hypertensive Diabetic Patients

    Not yet reported Sanofi 797 participants Est. completion 2008-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00367094

    Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

    Not yet reported Novartis 296 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Suspended NCT NCT00369538

    Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria

    Not yet reported University Hospital, Strasbourg, France 20 participants 1 site
    Other conditions: Proteinuria, Hypertension, End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00374855

    A Study in People With Mild Hypertension

    Not yet reported Eli Lilly and Company 153 participants Est. completion 2006-11 10 sites
    Other conditions: Mild Hypertension
    View official trial listing →
  • Completed NCT NCT00383929

    Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg

    Not yet reported AstraZeneca 1979 participants Est. completion 2007-10 132 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00386139

    A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients

    Not yet reported Novartis 881 participants Est. completion 2007-07 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00387517

    Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension

    Not yet reported Novartis 726 participants Est. completion 2007-08 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00388388

    Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects

    Not yet reported Sir Mortimer B. Davis - Jewish General Hospital 1 participants Est. completion 2009-12 1 site Stand-alone
    Prediabetes Other conditions: Pre-hypertension
    View official trial listing →
  • Completed NCT NCT00391846

    Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

    Not yet reported AstraZeneca 252 participants Est. completion 2009-01 39 sites
    Heart failure Other conditions: Ventricular Dysfunction, Left
    View official trial listing →
  • Completed NCT NCT00394394

    Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and Enalapril

    Not yet reported Hospital de Clinicas de Porto Alegre 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00396656

    Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients

    Not yet reported Novartis 30 participants Est. completion 2007-12 2 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00398541

    Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)

    Not yet reported Organon and Co 41 participants Est. completion 2007-06-01
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00400218

    Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)

    Not yet reported Organon and Co 62 participants Est. completion 2006-07-19
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00400777

    Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension

    Not yet reported Novartis 460 participants Est. completion 2008-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00402103

    An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure

    Not yet reported Novartis 556 participants Est. completion 2008-04 8 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00403481

    An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes

    Not yet reported Daiichi Sankyo 192 participants Est. completion 2007-12 27 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00424801

    Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris

    Not yet reported University of Aarhus 10 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Microvascular Angina, Hypertension
    View official trial listing →
  • Completed NCT NCT00425997

    Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension

    Not yet reported Novartis 480 participants Est. completion 2007-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00426478

    Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients

    Not yet reported Novartis 80 participants Est. completion 2007-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00430508

    Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

    Not yet reported Daiichi Sankyo 972 participants Est. completion 2008-05 55 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00430638

    A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

    Not yet reported Daiichi Sankyo 278 participants Est. completion 2007-10 29 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00430950

    Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

    Not yet reported Daiichi Sankyo 1011 participants Est. completion 2008-10 41 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00438113

    Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF

    Not yet reported Nova Scotia Health Authority 184 participants Est. completion 2016-09 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00439738

    Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults

    Not yet reported Novartis Pharmaceuticals 412 participants 5 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00441350

    Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension

    Not yet reported Menarini Group 1004 participants Est. completion 2008-05 65 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00443612

    Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing

    Not yet reported Sanofi 60 participants 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00447603

    A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)

    Not yet reported Organon and Co 40 participants Est. completion 2007-10-22 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00449111

    An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)

    Not yet reported Organon and Co 11 participants Est. completion 2006-09-30
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00457483

    Nijmegen Antihypertensive Management Improvement Study

    Not yet reported Radboud University Medical Center 120 participants Est. completion 2011-03 1 site
    Other conditions: Primary Hypertension
    View official trial listing →
  • Completed NCT NCT00459056

    The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients

    Not yet reported St. Paul Heart Clinic 25 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Abdominal Obesity, Hypertension
    View official trial listing →
  • Completed NCT NCT00478335

    Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus

    Not yet reported University of Colorado, Denver 4 participants Est. completion 2012-10 2 sites Stand-alone
    Other conditions: Nephrogenic Diabetes Insipidus
    View official trial listing →
  • Completed NCT NCT00480805

    HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

    Not yet reported Organon and Co 312 participants Est. completion 2002-10-16
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00492128

    Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

    Not yet reported Yokohama City University Medical Center 196 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00496834

    LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)

    Not yet reported Organon and Co 201 participants Est. completion 2009-09-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00500604

    Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension

    Not yet reported Sanofi 1617 participants Est. completion 2010-01 14 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00508365

    Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives

    Not yet reported GlaxoSmithKline 62 participants Est. completion 2008-06-03 20 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00509470

    Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine

    Not yet reported Tokyo University 75 participants Est. completion 2012-10 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00523744

    Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

    Not yet reported Novartis 257 participants Est. completion 2007-12 2 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00526279

    COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus

    AstraZeneca 9000 participants Est. completion 2008-08 3 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00535925

    Nephropathy In Type 2 Diabetes and Cardio-renal Events

    Not yet reported University of Campania Luigi Vanvitelli 850 participants Est. completion 2019-05 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00546052

    A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)

    Not yet reported Organon and Co 1738 participants Est. completion 2008-01-01 Stand-alone
    Other conditions: Hypertension, Metabolic Disorder
    View official trial listing →
  • Completed NCT NCT00548067

    Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

    Not yet reported Novartis 111 participants Est. completion 2008-03 5 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00549510

    Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.

    Not yet reported GlaxoSmithKline 29 participants Est. completion 2007-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00552708

    A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL.

    Not yet reported GlaxoSmithKline 55 participants Est. completion 2007-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00555217

    VA NEPHRON-D: Diabetes iN Nephropathy Study

    Not yet reported US Department of Veterans Affairs 1448 participants Est. completion 2014-10 31 sites Stand-alone
    Type 2 diabetes Other conditions: Kidney Disease, Nephropathy
    View official trial listing →
  • Completed NCT NCT00557128

    Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril.

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2007-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00563901

    Analyzing How Genetics May Affect Response to High Blood Pressure Medications

    University of Alabama at Birmingham 37939 participants Est. completion 2004-05 2 sites
    Other conditions: Hypertension, Coronary Disease, Cerebrovascular Accident
    View official trial listing →
  • Completed NCT NCT00567307

    Polypill For Prevention of Cardiovascular Disease

    Not yet reported Wake Forest University Health Sciences 216 participants Est. completion 2010-01 3 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00574834

    Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes

    Not yet reported University of Maryland, Baltimore 17 participants Est. completion 2014-08 1 site
    Metabolic syndrome
    View official trial listing →
  • Terminated NCT NCT00582114

    Hypertension in Hemodialysis Patients (Aim 3)

    Not yet reported Indiana University 200 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Hemodialysis, Hypertension, Left Ventricular Hypertrophy
    View official trial listing →
  • Completed NCT NCT00607633

    Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH

    AstraZeneca 686 participants Est. completion 2007-10
    Other conditions: Essential Hypertension, Left Ventricular Hypertrophy
    View official trial listing →
  • Completed NCT NCT00617877

    Antihypertensive Response to Losartan and Genetic Polymorphisms

    Not yet reported Merck Sharp & Dohme LLC 800 participants Est. completion 2009-06 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00621153

    Candesartan Effect in Second Stage Arterial Hypertension

    Not yet reported AstraZeneca 214 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Stage II Hypertension
    View official trial listing →
  • Completed NCT NCT00624065

    Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure

    Not yet reported GlaxoSmithKline 348 participants Est. completion 2008-08 76 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00638482

    Dose-Dependent Effect of Thiazide in Dent's Disease Hypercalciuria

    Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris 10 participants Est. completion 2005-12 1 site Stand-alone
    Other conditions: Dent's Disease, Nephrolithiasis
    View official trial listing →
  • Completed NCT NCT00642096

    Factorial Study of Metoprolol Succinate TOPROL-XL (324A)

    Not yet reported AstraZeneca 1900 participants Est. completion 2004-07 Stand-alone
    Other conditions: High Blood Pressure (Hypertension).
    View official trial listing →
  • Completed NCT NCT00648011

    Food Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg

    Not yet reported Mylan Pharmaceuticals Inc 44 participants Est. completion 2003-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649038

    Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg

    Not yet reported Mylan Pharmaceuticals Inc 24 participants Est. completion 2002-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649233

    Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopressor HCT® Tablets 100/50 mg

    Not yet reported Mylan Pharmaceuticals Inc 32 participants Est. completion 2003-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649324

    Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mg

    Not yet reported Mylan Pharmaceuticals Inc 40 participants Est. completion 2005-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649389

    Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension

    Not yet reported Daiichi Sankyo 2500 participants Est. completion 2009-12 232 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00649441

    Fasting Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg

    Not yet reported Mylan Pharmaceuticals Inc 60 participants Est. completion 2003-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649597

    Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg

    Not yet reported Mylan Pharmaceuticals Inc 56 participants Est. completion 2002-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649688

    Fasting Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg and Lopressor HCT® Tablets 100/50 mg

    Not yet reported Mylan Pharmaceuticals Inc 32 participants Est. completion 2003-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00651287

    A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension

    Not yet reported Pfizer 200 participants Est. completion 2004-06 3 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00654745

    18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

    Not yet reported Daiichi Sankyo 207 participants Est. completion 2009-06 21 sites Stand-alone
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT00656331

    The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.

    Not yet reported University of New Mexico Est. completion 2012-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00657241

    Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril

    Not yet reported State University of New York at Buffalo 30 participants Est. completion 2010-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00659607

    Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension

    Boehringer Ingelheim 6901 participants 326 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00661895

    Black Education and Treatment of Hypertension (BEAT HTN)

    Not yet reported Creighton University 99 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00666536

    The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy

    Not yet reported Novartis 728 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00670566

    Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients

    Not yet reported Sanofi 503 participants 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00671424

    A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide

    Not yet reported GlaxoSmithKline 48 participants Est. completion 2008-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00673790

    The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

    Not yet reported Forest Laboratories 537 participants Est. completion 2010-07-09 88 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00684489

    Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

    Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00687206

    Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage

    Not yet reported Federico II University 20 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Hypertension, Ventricular Remodeling, Erectile Dysfunctions
    View official trial listing →
  • Completed NCT NCT00698646

    Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

    Not yet reported Novartis Pharmaceuticals 384 participants Est. completion 2009-06 20 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00705575

    Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension

    Not yet reported Novartis 688 participants Est. completion 2009-04 8 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00708344

    ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination

    Not yet reported Sanofi 832 participants Est. completion 2009-07 16 sites
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT00713011

    Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients

    Not yet reported Bayer Est. completion 2009-03 Stand-alone
    Other conditions: Diabetic Nephropathies, Hypertension
    View official trial listing →
  • Completed NCT NCT00734630

    Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients

    Not yet reported Forest Laboratories 491 participants Est. completion 2010-05 75 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00739596

    Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans

    Not yet reported Novartis Pharmaceuticals 332 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00743197

    Women With Chest Pain and Normal Coronary Arteries Study

    Not yet reported Northwestern University 3 participants Est. completion 2010-05 1 site
    Other conditions: Chest Pain
    View official trial listing →
  • Completed NCT NCT00744237

    Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

    Not yet reported Forest Laboratories 231 participants 65 sites
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT00745953

    Regression of Fatty Heart by Valsartan Therapy

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2009-08 1 site
    Metabolic syndrome Other conditions: Lipotoxicity
    View official trial listing →
  • Completed NCT NCT00751829

    Isolated Systolic Hypertension in the Elderly and Very Elderly

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 417 participants Est. completion 2005-02 1 site Stand-alone
    Other conditions: Isolated Systolic Hypertension
    View official trial listing →
  • Completed NCT NCT00760266

    Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population

    Not yet reported Novartis 451 participants Est. completion 2009-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00761904

    The Effect of Providing Free Samples of Generic Cardiovascular Medications to Physicians

    Not yet reported Brigham and Women's Hospital 660 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00765674

    Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension

    Not yet reported Novartis 1191 participants Est. completion 2009-08 12 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00765947

    Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension

    Not yet reported Novartis 256 participants Est. completion 2009-08 4 sites Stand-alone
    Other conditions: Essential Hypertension ( Mild to Moderate)
    View official trial listing →
  • Completed NCT NCT00772499

    Vascular Improvement With Olmesartan Medoxomil Study

    Not yet reported Daiichi Sankyo 100 participants Est. completion 2005-07 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT00773084

    Aliskiren and Renin Inhibition in Diastolic Heart Failure

    Not yet reported Texas Tech University Health Sciences Center Est. completion 2009-08 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00775814

    Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

    Not yet reported Takeda 188 participants Est. completion 2008-09 24 sites Stand-alone
    Other conditions: Obesity, Hypertension
    View official trial listing →
  • Completed NCT NCT00776646

    Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

    Not yet reported Ranbaxy Laboratories Limited 36 participants Est. completion 2006-08 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00777972

    Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions

    Not yet reported Ranbaxy Laboratories Limited 34 participants Est. completion 2003-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00778674

    Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions

    Not yet reported Ranbaxy Laboratories Limited 30 participants Est. completion 2004-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00778713

    Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions

    Not yet reported Ranbaxy Laboratories Limited 33 participants Est. completion 2003-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00778726

    Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting Conditions

    Not yet reported Ranbaxy Laboratories Limited 42 participants Est. completion 2004-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00787605

    Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus

    Not yet reported Novartis 860 participants Est. completion 2010-01 1 site Stand-alone
    Other conditions: Hypertension, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00791258

    A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure

    Not yet reported Daiichi Sankyo 999 participants Est. completion 2009-09 72 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00795847

    Morning Hypertension and Preminent Therapy Study

    Not yet reported Kurume University 216 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00796159

    Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide

    Pfizer 1723 participants Est. completion 2008-12
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00797316

    Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension

    Not yet reported Novartis 532 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00797862

    Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension

    Not yet reported Novartis 1254 participants Est. completion 2010-11 10 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00806585

    Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)

    Not yet reported Merck Sharp & Dohme LLC 620 participants Est. completion 2010-06
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00811226

    Assessment of the Effectiveness of OLMETEC® and OLMETEC PLUS® for Treatment of Hypertension in Stage I and II Patients (Study P05254)(COMPLETED)

    Schering-Plough 450 participants Est. completion 2008-01
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00813722

    Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment

    Not yet reported University of Sao Paulo 400 participants Est. completion 2009-06 2 sites
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT00821574

    Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome

    Not yet reported Novartis 144 participants Est. completion 2007-03 Stand-alone
    Other conditions: Hypertension, Dyslypidaemia
    View official trial listing →
  • Completed NCT NCT00834067

    Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 60 participants Est. completion 2003-11 2 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00834600

    Renin Profiling in Selection of Initial Antihypertensive Drug

    Not yet reported The Louis & Rachel Rudin Foundation 185 participants Est. completion 2011-10 5 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00835042

    Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 60 participants Est. completion 2003-11 2 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00846365

    Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension

    Not yet reported Takeda 1085 participants Est. completion 2010-06 80 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00847834

    Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population

    Not yet reported Sanofi 968 participants 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00865124

    Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease

    Not yet reported Brigham and Women's Hospital 69 participants Est. completion 2014-05 1 site
    Type 2 diabetes Other conditions: Vascular Disease
    View official trial listing →
  • Completed NCT NCT00867490

    Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension

    Not yet reported Novartis 186 participants Est. completion 2009-08 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00871871

    Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)

    Not yet reported Merck Sharp & Dohme LLC 64 participants Est. completion 2010-03 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00872235

    Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

    Not yet reported Ranbaxy Laboratories Limited 40 participants Est. completion 2005-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00872586

    Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension

    Not yet reported Daiichi Sankyo 304 participants Est. completion 2007-08 8 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00874432

    Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease

    Not yet reported University of Wisconsin, Madison 43 participants Est. completion 2011-12 1 site
    Cardiovascular diseaseChronic kidney disease
    View official trial listing →
  • Completed NCT NCT00886288

    TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in Belgium

    Boehringer Ingelheim 2874 participants 936 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00886600

    A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 122 participants Est. completion 1992-08 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00887510

    Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)

    Not yet reported University of Florida 24 participants Est. completion 2009-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00890084

    Telmisartan Tab Hypertension

    Boehringer Ingelheim 2913 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00890591

    Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension

    Not yet reported Daiichi Sankyo 144 participants Est. completion 2007-08 Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00896389

    Salt Loading and Thiazide Intervention Study

    Not yet reported University of Maryland, Baltimore 124 participants Est. completion 2013-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00902304

    Valsartan Intensified Primary Care Reduction of Blood Pressure Study

    Not yet reported Novartis Pharmaceuticals 2337 participants Est. completion 2011-07 3 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00902538

    Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension

    Not yet reported Daiichi Sankyo 2204 participants Est. completion 2010-10 117 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00904215

    An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension

    Boehringer Ingelheim 1095 participants 11 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00909038

    Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational Study

    Boehringer Ingelheim 2411 participants 915 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00923091

    Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

    Not yet reported Daiichi Sankyo 2689 participants Est. completion 2011-03 133 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00923533

    A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers

    Not yet reported Boryung Pharmaceutical Co., Ltd 34 participants Est. completion 2009-08
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00926289

    Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension

    Not yet reported Boehringer Ingelheim 894 participants 106 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00927537

    Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®

    Bayer 2052 participants Est. completion 2011-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00935805

    Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy

    Hospital de Clinicas de Porto Alegre 124 participants Est. completion 2012-07 1 site
    Other conditions: Diabetes Mellitus, Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT00942994

    Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

    Not yet reported Novartis 412 participants 5 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00953680

    Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)

    Not yet reported Organon and Co 77 participants Est. completion 2004-07
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00976495

    Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes

    Not yet reported AstraZeneca 154 participants Est. completion 2010-11 12 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00990301

    A Study to Compare the Relative Bioavailability of Moexipril HCl/Hydrochlorothiazide in Healthy Adult Volunteers Under Fasting Conditions

    Not yet reported Paddock Laboratories, Inc. 48 participants 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT00994617

    Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension

    Not yet reported University of Cambridge 600 participants Est. completion 2014-12 13 sites Stand-alone
    Other conditions: Hypertension, Resistant to Conventional Therapy, Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00996281

    Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension

    Not yet reported Takeda 837 participants Est. completion 2011-11 26 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01009918

    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

    Not yet reported University of South Florida 468 participants Est. completion 2018-11 174 sites Stand-alone
    Other conditions: Breast Cancer, Cardiac Toxicity
    View official trial listing →
  • Withdrawn NCT NCT01009944

    Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study

    Not yet reported Brigham and Women's Hospital Est. completion 2019-03-19 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01012479

    Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension

    Not yet reported Takeda 107 participants Est. completion 2010-06 16 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01019590

    Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

    Not yet reported Mylan Pharmaceuticals Inc 36 participants Est. completion 2006-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01020214

    Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

    Not yet reported Mylan Pharmaceuticals Inc 36 participants Est. completion 2006-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01030458

    Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial

    Not yet reported KU Leuven 183 participants Est. completion 2012-03 7 sites
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT01033071

    Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

    Not yet reported Takeda 1071 participants Est. completion 2010-11 94 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01050062

    Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use

    Boehringer Ingelheim 1452 participants Est. completion 2011-12 314 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01056731

    A Clinical Study With Aliskiren Alone or in Combination Therapy With Diuretic Hctz in Venezuelan Hypertensive Patients.

    Not yet reported Novartis 253 participants Est. completion 2011-10 7 sites Stand-alone
    Other conditions: High Blood Pressure
    View official trial listing →
  • Completed NCT NCT01057537

    UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events

    Not yet reported Imperial College London 2004 participants Est. completion 2012-09 7 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01066572

    Paramedic Initiated Lisinopril For Acute Stroke Treatment

    Not yet reported Newcastle-upon-Tyne Hospitals NHS Trust 14 participants Est. completion 2011-12 4 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01070030

    Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension

    Not yet reported Novartis 230 participants Est. completion 2010-10 3 sites
    Other conditions: Stage II Hypertension
    View official trial listing →
  • Completed NCT NCT01080742

    An Observational Study to Evaluate the Efficacy of Lodoz in a Population of Hypertensive Patients

    Merck KGaA, Darmstadt, Germany 1007 participants Est. completion 2011-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01087749

    Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers

    Not yet reported University of California, San Francisco 24 participants Est. completion 2012-12 1 site
    Other conditions: Kidney Disease
    View official trial listing →
  • Completed NCT NCT01096667

    Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)

    Not yet reported Merck Sharp & Dohme LLC 194 participants Est. completion 2011-02-25
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01099397

    Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study

    University of Florida 26 participants Est. completion 2010-12 1 site
    Other conditions: Prediabetic State
    View official trial listing →
  • Completed NCT NCT01102465

    Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions

    Not yet reported Roxane Laboratories 25 participants Est. completion 2005-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01102478

    Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions

    Not yet reported Roxane Laboratories 30 participants Est. completion 2005-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01109043

    Bisoprolol in Hypertension: Effect on Concomitant Elevated Heart Rate

    Merck KGaA, Darmstadt, Germany 351 participants Est. completion 2010-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01126697

    Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies

    Not yet reported, Not yet reported Cooperative International Neuromuscular Research Group 63 participants Est. completion 2017-12 7 sites
    Other conditions: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb Girdle Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT01138423

    Treatment of Adiposity Related hypErTension (TARGET)

    Not yet reported UMC Utrecht 32 participants Est. completion 2012-02 1 site Stand-alone
    Metabolic syndrome Other conditions: Hypertension, Abdominal Obesity
    View official trial listing →
  • Completed NCT NCT01149486

    Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 20 participants Est. completion 2004-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01172431

    Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency

    Not yet reported West China Hospital 240 participants Est. completion 2013-12 1 site
    Other conditions: Hypertension, Renal Insufficiency
    View official trial listing →
  • Status unknown NCT NCT01180205

    Telmisartan, Amlodipine and Flow Mediated Dilation

    Not yet reported Johannes Gutenberg University Mainz 576 participants Est. completion 2011-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01181284

    Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)

    Mayo Clinic 24 participants Est. completion 2011-07 1 site
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT01190436

    A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Filipino Hypertensive Subjects With Diabetes

    Not yet reported Merck KGaA, Darmstadt, Germany 125 participants Est. completion 2011-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01198249

    Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension

    Not yet reported Yonsei University 23 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01218711

    Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions.

    Not yet reported Torrent Pharmaceuticals Limited
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01218724

    Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fed Conditions

    Not yet reported Torrent Pharmaceuticals Limited 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01219556

    Xirtam H Combination In the Treatment of Hypertension Evaluation Study.

    Bayer 8704 participants Est. completion 2013-02 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01234922

    Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

    Not yet reported Wake Forest University Health Sciences 6 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Hypertension, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT01235377

    Tolerance to Target Doses of Thiazides in Actual Practice: A Feasibility Study

    Not yet reported VA Pharmacy Benefits Management Strategic Healthcare Group 20 participants Est. completion 2014-02 5 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01245608

    Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.

    Not yet reported Tehran University of Medical Sciences 2400 participants Est. completion 2018-09 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01256411

    A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 341 participants Est. completion 2012-04 33 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Terminated NCT NCT01259297

    A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People

    Not yet reported Novartis Pharmaceuticals 2336 participants Est. completion 2012-11 185 sites Stand-alone
    Other conditions: Cardiovascular Events
    View official trial listing →
  • Status unknown NCT NCT01271374

    Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome

    Not yet reported InVasc Therapeutics, Inc. 80 participants Est. completion 2011-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01271985

    Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill

    Not yet reported Tehran University of Medical Sciences 8410 participants Est. completion 2019-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01276288

    Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 Diabetes

    Not yet reported Boehringer Ingelheim 23 participants 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01294631

    A Pharmacodynamics, Pharmacokinetics, and Safety Study of Hydrochlorothiazide and Canagliflozin in Healthy Volunteers

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 30 participants Est. completion 2011-07
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01302691

    MK-0954E Study in Participants With Hypertension (MK-0954E-357)

    Not yet reported Merck Sharp & Dohme LLC 327 participants Est. completion 2012-04-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01302899

    To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy

    Not yet reported Novartis Pharmaceuticals 8 participants Est. completion 2011-12 2 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01307033

    A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)

    Not yet reported Organon and Co 278 participants Est. completion 2012-12-04 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01309828

    Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease

    Not yet reported Takeda 153 participants Est. completion 2012-10 53 sites
    Other conditions: Safety
    View official trial listing →
  • Completed NCT NCT01324388

    A Study of the Effect of LY2189265 on Two Blood Pressure Drugs

    Not yet reported Eli Lilly and Company 51 participants Est. completion 2011-08 3 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT01326676

    Polypill Effects on Sub Clinical Atherosclerosis (PESCA) Trial

    Not yet reported Imperial College London Est. completion 2012-09 3 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01368185

    Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366)

    Organon and Co 1705 participants Est. completion 2010-08
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01370655

    A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)

    Not yet reported Merck Sharp & Dohme LLC 46 participants Est. completion 2012-01-26
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01375244

    Comparative Bioavailability Study of Lisinopril Tablets, 10 mg

    Not yet reported Par Pharmaceutical, Inc. 36 participants Est. completion 1999-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01375322

    ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria

    Not yet reported TSH Biopharm Corporation Limited 226 participants Est. completion 2010-06 4 sites
    Type 2 diabetes Other conditions: Hypertension, Albuminuria
    View official trial listing →
  • Completed NCT NCT01392534

    Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting

    Bayer 1586 participants Est. completion 2010-12 1 site
    Other conditions: Primary Hypertension
    View official trial listing →
  • Completed NCT NCT01398267

    A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril

    Not yet reported Hoffmann-La Roche 55 participants Est. completion 2012-10 4 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01409837

    The Effect and Safety of Lisinopril in Non-hypertensive Men With Infertility From Low Sperm Count

    Not yet reported University Of Nigeria Teaching Hospital 33 participants Est. completion 2006-12 1 site Stand-alone
    Other conditions: Oligospermia
    View official trial listing →
  • Completed NCT NCT01431508

    A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)

    Not yet reported Organon and Co 15 participants Est. completion 2009-06-01
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01432106

    The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome

    Not yet reported University of Michigan Est. completion 2012-12 1 site
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01437371

    Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?

    Not yet reported University Hospital, Clermont-Ferrand 35 participants Est. completion 2014-06 1 site
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT01480791

    Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries

    Not yet reported Sir Mortimer B. Davis - Jewish General Hospital Est. completion 2013-12 1 site Stand-alone
    Other conditions: Hypertension, Diabetes
    View official trial listing →
  • Completed NCT NCT01503814

    Simplified Cardiovascular Management Study

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 2086 participants Est. completion 2015-09 3 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01506505

    The Evening Versus Morning Polypill Utilization Study

    Not yet reported UMC Utrecht 78 participants Est. completion 2013-07 1 site Stand-alone
    Cardiovascular disease Other conditions: Cerebrovascular Disease, Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT01518166

    Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH

    Not yet reported Novo Nordisk A/S 70 participants Est. completion 2007-04 1 site Added to GLP-1
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01519635

    Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension

    Not yet reported Centre Hospitalier Universitaire Vaudois 24 participants Est. completion 2014-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01535235

    ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study

    Not yet reported University of California, San Francisco 31 participants Est. completion 2014-12 1 site
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT01560806

    Intervention Study on Hypertension Management Combined With Health Promotion at Commune Level

    Not yet reported Vietnam National Heart Institute 2400 participants Est. completion 2009-12 1 site
    Other conditions: Hypertension, Cardiovascular Risk Factor, Lifestyle
    View official trial listing →
  • Completed NCT NCT01575652

    Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients

    Not yet reported Turkish Nephrology Association 43 participants Est. completion 2009-01
    Other conditions: Disorders Associated With Peritoneal Dialysis
    View official trial listing →
  • Suspended NCT NCT01620788

    Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment

    Not yet reported EMS 636 participants Est. completion 2023-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01658657

    A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension

    Not yet reported University of North Carolina, Chapel Hill 17 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Hypertension, Plasma Renin Activity
    View official trial listing →
  • Completed NCT NCT01669434

    Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

    Not yet reported University of Nebraska 291 participants Est. completion 2016-12-01 1 site
    Other conditions: Hypotension on Induction
    View official trial listing →
  • Completed NCT NCT01692717

    Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + Hydrochlorothiazide

    Not yet reported Azidus Brasil 90 participants Est. completion 2013-05-31 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT01700075

    Physical and Chemical Study of Atherosclerosis Mechanisms

    Not yet reported Nazarbayev University 97 participants Est. completion 2011-12 1 site
    Cardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis of Femoral Artery
    View official trial listing →
  • Completed NCT NCT01712126

    Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions

    Not yet reported Roxane Laboratories 40 participants Est. completion 2007-09 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01712139

    Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions

    Not yet reported Roxane Laboratories 37 participants Est. completion 2007-09 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01715584

    Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01735344

    Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition

    Not yet reported IPCA Laboratories Ltd. 40 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Fed
    View official trial listing →
  • Withdrawn NCT NCT01748123

    EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative Network

    Not yet reported Johns Hopkins University Est. completion 2018-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01767298

    Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)

    Not yet reported Damanhour University 24 participants Est. completion 2012-12
    Other conditions: Healthy Normotensive Participants
    View official trial listing →
  • Status unknown NCT NCT01774656

    Remission From Stage D Heart Failure

    Not yet reported University of Louisville 40 participants Est. completion 2017-12 6 sites Stand-alone
    Heart failure
    View official trial listing →
  • Terminated NCT NCT01804777

    Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

    Not yet reported University of New Mexico 9 participants Est. completion 2014-12 1 site
    Other conditions: Proteinuria, Hypertension, Type II Diabetes
    View official trial listing →
  • Completed NCT NCT01819220

    Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome

    Not yet reported Yonsei University 16 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01822860

    Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function

    Not yet reported Creighton University Est. completion 2015-02 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01828359

    The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.

    Not yet reported Hanmi Pharmaceutical Company Limited 199 participants Est. completion 2013-01
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01831700

    Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions

    Not yet reported IPCA Laboratories Ltd. 48 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Fasting
    View official trial listing →
  • Terminated NCT NCT01837069

    Risk Factor Control Before Orthopedic Surgery

    Not yet reported NYU Langone Health 198 participants Est. completion 2018-04-02 1 site
    OsteoarthritisCardiovascular disease
    View official trial listing →
  • Completed NCT NCT01858610

    Drug Interaction Between Irbesartan and Hydrochlorothiazide

    Not yet reported Damanhour University 18 participants Est. completion 2013-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01858623

    Pharmacokinetic Interactions of Losartan and Hydrochlorothiazide

    Not yet reported Damanhour University 18 participants Est. completion 2013-03
    Other conditions: Healthy Normotensive Participants
    View official trial listing →
  • Terminated NCT NCT01867047

    ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients

    Not yet reported Duke University 59 participants Est. completion 2016-06-24 1 site Stand-alone
    Other conditions: Adverse Effects of Angiotensin-converting-enzyme Inhibitors, Hypotension
    View official trial listing →
  • Completed NCT NCT01880528

    Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer

    Not yet reported Mayo Clinic 23 participants Est. completion 2019-01-29 3 sites Stand-alone
    Other conditions: Dyspnea, Non-small Cell Lung Cancer, Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT01885559

    HALT Progression of Polycystic Kidney Disease Study B

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 486 participants Est. completion 2014-06 7 sites
    Other conditions: Kidney, Polycystic
    View official trial listing →
  • Completed NCT NCT01891513

    ACE Inhibitors Combined With Exercise for Seniors - Pilot Study

    University of Florida 104 participants Est. completion 2017-06 1 site
    Other conditions: Hypertension, Aging
    View official trial listing →
  • Status unknown NCT NCT01901549

    Renal Denervation in Patients After Acute Coronary Syndrome

    Not yet reported Meshalkin Research Institute of Pathology of Circulation 80 participants Est. completion 2016-06 1 site
    Other conditions: Acute Coronary Syndrome, Arterial Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01922141

    Aliskiren Study of Safety and Efficacy in Senior Hypertensives

    Not yet reported Novartis Pharmaceuticals Est. completion 2018-06 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01964079

    Comparision of Blood Pressure Variability Between Amlodipine and Losartan

    Not yet reported Wonju Severance Christian Hospital 144 participants Est. completion 2017-05 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01975246

    Add-on to Micamlo BP Trial

    Not yet reported Boehringer Ingelheim 309 participants Est. completion 2014-07 30 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01977430

    Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function

    Not yet reported Corporacion Parc Tauli 36 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Chronic Kidney Insufficiency, Hemodialysis Treatment, Diuresis Preserved
    View official trial listing →
  • Completed NCT NCT01982695

    Cardiomyopathy in DMD: Lisinopril vs. Losartan

    Not yet reported Nationwide Children's Hospital 23 participants Est. completion 2013-09 6 sites
    Other conditions: Duchenne Muscular Dystrophy (DMD), Cardiomyopathy
    View official trial listing →
  • Terminated NCT NCT01983462

    Vascular Dysfunction in Human Obesity Hypertension

    Not yet reported Gary L. Pierce 33 participants Est. completion 2020-06 1 site
    Other conditions: Obesity, Prehypertension, Hypertension
    View official trial listing →
  • Completed NCT NCT01984164

    CAndesartan vs LIsinopril Effects on the BRain

    Not yet reported Emory University 176 participants Est. completion 2018-12-03 1 site
    Other conditions: Hypertension, Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT01996085

    Non-invasive Haemodynamic Assessment in Hypertension

    Not yet reported Military Institute od Medicine National Research Institute 144 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT02016183

    Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)

    Takeda 3222 participants Est. completion 2012-09-30 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02045459

    Microvascular Disease Exercise Trial

    Not yet reported University of Virginia 79 participants Est. completion 2021-05-17 2 sites Stand-alone
    Other conditions: Coronary Microvascular Disease
    View official trial listing →
  • Completed NCT NCT02046395

    Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus

    Not yet reported Tulane University School of Medicine 28 participants Est. completion 2019-12 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02057328

    Comparative Study of the Effects of Telmisartan and Nebivolol

    Not yet reported Aristotle University Of Thessaloniki 80 participants Est. completion 2017-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02070510

    A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects

    Not yet reported Novo Nordisk A/S 52 participants Est. completion 2014-08-20 1 site Added to GLP-1
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT02072330

    Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

    Not yet reported, Not yet reported Takeda 353 participants Est. completion 2013-12 13 sites Stand-alone
    Other conditions: Grade I or II Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02094924

    A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323

    Not yet reported GlaxoSmithKline 16 participants Est. completion 2014-05-23 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02128386

    Medication Adherence and "True" Resistance in Patients With Resistant Hypertension

    Charite University, Berlin, Germany 50 participants Est. completion 2016-03 1 site
    Other conditions: Hypertensive Disease, Hypertension, Resistant to Conventional Therapy
    View official trial listing →
  • Completed NCT NCT02129192

    Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use

    Not yet reported Boehringer Ingelheim 72 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02172586

    Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients

    Not yet reported Boehringer Ingelheim 363 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02175355

    Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)

    Not yet reported Boehringer Ingelheim 1039 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02176512

    Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects

    Not yet reported Boehringer Ingelheim 20 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02177422

    Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension

    Not yet reported Boehringer Ingelheim 489 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02177435

    Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension

    Not yet reported Boehringer Ingelheim 491 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02177500

    Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy

    Not yet reported Boehringer Ingelheim 327 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02183675

    Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 36 participants Est. completion 2014-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02183701

    Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

    Not yet reported Boehringer Ingelheim 715 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02184858

    Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension

    Not yet reported University Ghent 13 participants Est. completion 2018-09-17 1 site Stand-alone
    Other conditions: Primary Hypertension, Secondary Hypertension
    View official trial listing →
  • Completed NCT NCT02185417

    Diuretic Comparison Project

    Not yet reported VA Office of Research and Development 20723 participants Est. completion 2022-12-29 70 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02187523

    Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy Subjects

    Not yet reported Boehringer Ingelheim 32 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02200822

    Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients

    Not yet reported Hasselt University 80 participants Est. completion 2019-02 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02214498

    Treatment of HYpertension: Morning Versus Evening

    Not yet reported Erasmus Medical Center 120 participants Est. completion 2017-05 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT02217852

    Treatment of Hypertension in Tibetan Adult Population

    Not yet reported West China Hospital 800 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02222480

    A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

    Not yet reported Boryung Pharmaceutical Co., Ltd 103 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT02232880

    Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation

    Not yet reported Vanderbilt University Medical Center 1 participants Est. completion 2015-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242383

    Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension

    Boehringer Ingelheim 13248 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242396

    A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)

    Boehringer Ingelheim 5248 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242825

    Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus

    Boehringer Ingelheim 8148 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242864

    Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure

    Boehringer Ingelheim 1527 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242877

    TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or Older

    Boehringer Ingelheim 3320 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02243566

    Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)

    Boehringer Ingelheim 2707 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02248129

    Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide

    Boehringer Ingelheim 4255 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02255253

    Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population

    Not yet reported The George Institute for Global Health, China 1410 participants Est. completion 2015-03 14 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02262572

    Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects

    Not yet reported Boehringer Ingelheim 24 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02262611

    Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

    Boehringer Ingelheim 266 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02262780

    Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 20 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02262858

    Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II

    Not yet reported Boehringer Ingelheim 68 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02276378

    Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 32 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02277691

    A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension

    Not yet reported Takeda 341 participants Est. completion 2016-04-25 38 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02278471

    The SCCS Polypill Pilot Trial

    Not yet reported Vanderbilt University 303 participants Est. completion 2018-06-27 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02294539

    Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients

    Not yet reported Chong-Jin Kim 231 participants Est. completion 2016-05-18 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02336607

    The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.

    Not yet reported AstraZeneca 529 participants Est. completion 2006-08
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02351973

    Comparison of Single and Combination Diuretics in Low-Renin Hypertension

    Not yet reported University of Cambridge 423 participants Est. completion 2015-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT02358642

    Drug to Prevent Pneumonia in the Tube Fed

    Not yet reported Chinese University of Hong Kong 93 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Pneumonia, Neurological Dysphagia
    View official trial listing →
  • Status unknown NCT NCT02369926

    Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

    Not yet reported Transparency Life Sciences 20 participants 1 site
    Other conditions: Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Completed NCT NCT02373163

    INTERVENCION Trial

    Not yet reported Prevencion 166 participants Est. completion 2016-06-01 1 site
    Other conditions: Blood Pressure, High
    View official trial listing →
  • Completed NCT NCT02377661

    Lowering Blood Pressure in Primary Care in Vienna

    Not yet reported Wilhelminenspital Vienna 229 participants Est. completion 2017-05-30 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02412761

    Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension

    Not yet reported The University of Texas Health Science Center, Houston 42 participants Est. completion 2016-07 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02433119

    The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy

    Not yet reported Dong-A ST Co., Ltd. 238 participants Est. completion 2016-09-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02441842

    Evaluation of Periop Biochemical Stress Factors in Craniotomy Neurosurgical Procedure With Respect to Preop Hypertension

    Not yet reported Milton S. Hershey Medical Center 85 participants Est. completion 2008-12
    Other conditions: Perioperative Hypertension
    View official trial listing →
  • Completed NCT NCT02449811

    RAS Peptide Profiles in Patients With Arterial Hypertension

    Insel Gruppe AG, University Hospital Bern 107 participants Est. completion 2018-11 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02466490

    Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension

    Not yet reported Stendhal Americas, S.A. 272 participants Est. completion 2014-02 13 sites Stand-alone
    Other conditions: Hypertension, Essential
    View official trial listing →
  • Withdrawn NCT NCT02483936

    Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control

    Not yet reported EMS
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Withdrawn NCT NCT02493322

    Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

    Not yet reported EMS Stand-alone
    Other conditions: Essential Arterial Hypertension
    View official trial listing →
  • Withdrawn NCT NCT02521233

    Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

    Not yet reported EMS Est. completion 2017-08
    Other conditions: Essential Arterial Hypertension
    View official trial listing →
  • Withdrawn NCT NCT02521246

    Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control

    Not yet reported EMS Est. completion 2017-08
    Other conditions: Essential Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT02591160

    Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism

    Not yet reported University of Missouri-Columbia 2 participants Est. completion 2017-09-13 1 site
    Other conditions: Hyperparathyroidism
    View official trial listing →
  • Completed NCT NCT02591628

    Treatment of Hypertension In Adults With ThiaZIDES: Pragmatic Trial Pilot Study

    Not yet reported HealthPartners Institute 2027 participants Est. completion 2017-07 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02603809

    Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension

    Not yet reported Idorsia Pharmaceuticals Ltd. 1659 participants Est. completion 2017-04-07 90 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT02623036

    The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors

    Not yet reported Memorial Health University Medical Center 20 participants Est. completion 2018-04 1 site
    Other conditions: Hypertension, Resistant to Conventional Therapy
    View official trial listing →
  • Completed NCT NCT02641899

    Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs

    Not yet reported Intarcia Therapeutics 33 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02646397

    Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension

    Not yet reported Shanghai Changzheng Hospital 508 participants Est. completion 2017-12 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT02682459

    ACE-inhibitors in Extracapillary Glomerulonephritis

    Not yet reported Monia Lorini 22 participants Est. completion 2019-12 2 sites Stand-alone
    Other conditions: Extracapillary Glomerulonephritis
    View official trial listing →
  • Completed NCT NCT02699125

    Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic

    Not yet reported University of California, San Diego 41 participants Est. completion 2016-08 Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02738632

    Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients

    Not yet reported IlDong Pharmaceutical Co Ltd 300 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02739672

    Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

    Not yet reported IlDong Pharmaceutical Co Ltd 40 participants Est. completion 2016-04-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02742467

    Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans

    Not yet reported University of Abuja 702 participants Est. completion 2018-06-01 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02744456

    N-of-1 Trials for Blood Pressure Medications in Adults

    Not yet reported Columbia University 10 participants Est. completion 2017-12-31 1 site
    Other conditions: Hypertension, High Blood Pressure
    View official trial listing →
  • Completed NCT NCT02774460

    The Precision Hypertension Care Study

    Not yet reported Uppsala University 280 participants Est. completion 2021-06-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02814552

    OPTImizing Precision of Hypertension Care to Maximize Blood Pressure Control Pilot (OPTI-BP Pilot)

    Not yet reported University of Florida 47 participants Est. completion 2018-06-30 3 sites
    Other conditions: High Blood Pressure
    View official trial listing →
  • Completed NCT NCT02824718

    Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism

    Not yet reported Assistance Publique - Hôpitaux de Paris 16 participants Est. completion 2020-05-28 1 site
    Other conditions: Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment
    View official trial listing →
  • Completed NCT NCT02847338

    Comparison of Optimal Hypertension Regimens

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 940 participants Est. completion 2023-10 14 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02962258

    BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions

    Not yet reported Torrent Pharmaceuticals Limited 34 participants Est. completion 2011-06 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03006796

    Observational Study of Azilsartan/Chlorthalidone and Irbesartan/Hydrochlorothiazide in Hypertension and Obesity.

    Russian Heart Failure Society 94 participants Est. completion 2020-03-31 1 site
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Status unknown NCT NCT03015311

    Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 8000 participants Est. completion 2021-12-31 42 sites Stand-alone
    Other conditions: Primary Hypertension
    View official trial listing →
  • Completed NCT NCT03021265

    To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension

    Boehringer Ingelheim 676 participants Est. completion 2019-04-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03031496

    Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions

    Not yet reported GlaxoSmithKline 42 participants Est. completion 2017-04-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03032315

    Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

    Not yet reported IlDong Pharmaceutical Co Ltd 44 participants Est. completion 2016-12-27 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03057431

    Hydrochlorothiazide for Kidney Stone Recurrence Prevention

    Not yet reported Insel Gruppe AG, University Hospital Bern 416 participants Est. completion 2022-04-30 12 sites Stand-alone
    Other conditions: Nephrolithiasis
    View official trial listing →
  • Status unknown NCT NCT03082742

    The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients

    Not yet reported University of Sao Paulo General Hospital 52 participants Est. completion 2018-06 1 site
    Chronic kidney disease Other conditions: Secondary Hyperparathyroidism
    View official trial listing →
  • Terminated NCT NCT03109795

    Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System

    Not yet reported University of Iowa 35 participants Est. completion 2023-06-30 1 site
    Other conditions: Anxiety, Hypertension
    View official trial listing →
  • Completed NCT NCT03115853

    The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function

    Not yet reported Vanderbilt University Medical Center 31 participants Est. completion 2012-01 1 site
    Other conditions: High Blood Pressure
    View official trial listing →
  • Completed NCT NCT03170336

    A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein

    Not yet reported Guangdong Provincial People's Hospital 40 participants Est. completion 2020-08-01 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Terminated NCT NCT03179163

    Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans

    Not yet reported, Not yet reported Penn State University 10 participants Est. completion 2022-12-31 1 site
    Other conditions: Hypertension,Essential
    View official trial listing →
  • Status unknown NCT NCT03195023

    Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)

    Not yet reported Hospital General Universitario Gregorio Marañon 106 participants Est. completion 2022-12 1 site
    Other conditions: Renal Insufficiency, Chronic, Proteinuria
    View official trial listing →
  • Completed NCT NCT03198793

    Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins

    Not yet reported Quantum Genomics SA 256 participants Est. completion 2018-11-12 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT03201939

    Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria

    Not yet reported Vanderbilt University Medical Center 66 participants Est. completion 2025-02-01 1 site
    Other conditions: HIV/AIDS, Albuminuria, Kidney Diseases, Genetic Predisposition
    View official trial listing →
  • Withdrawn NCT NCT03205137

    Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

    Boehringer Ingelheim Est. completion 2022-07-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT03249285

    Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)

    Not yet reported Ospedale San Raffaele 300 participants Est. completion 2018-11 3 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03276598

    A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension

    Not yet reported Helsinki University Central Hospital 233 participants Est. completion 2004-04-01 1 site
    Other conditions: Hypertension, Pharmacogenetics
    View official trial listing →
  • Completed NCT NCT03387657

    A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide

    Not yet reported Sanofi 16 participants Est. completion 2018-03-02 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03390465

    Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

    Not yet reported Boryung Pharmaceutical Co., Ltd 36 participants Est. completion 2018-01-30 1 site
    Other conditions: Drug-Drug Interaction
    View official trial listing →
  • Withdrawn NCT NCT03392740

    Prophylactic Lisinopril to Prevent Anthracycline Cardiomyopathy.

    Not yet reported Ascension Health Est. completion 2018-12-15 1 site Stand-alone
    Heart failure Other conditions: Cardiomyopathy Due to Drug
    View official trial listing →
  • Active, not recruiting NCT NCT03417388

    Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

    Not yet reported Cedars-Sinai Medical Center 2476 participants Est. completion 2026-09-14 81 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT03423355

    Dapagliflozin Effect on Erythropoiesis and Physical Fitness

    Not yet reported University Hospital Tuebingen Est. completion 2023-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03461003

    N-of-1 Trials In Children With Hypertension

    Not yet reported The University of Texas Health Science Center, Houston 49 participants Est. completion 2021-05-02 1 site Stand-alone
    Other conditions: Pediatric Hypertension
    View official trial listing →
  • Status unknown NCT NCT03502031

    Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy

    Not yet reported James A. Tumlin, MD 72 participants Est. completion 2024-10-01 2 sites
    Chronic kidney disease Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Status unknown NCT NCT03578042

    Fixed-Free HTN Trial

    Not yet reported Hotel Dieu de France Hospital 100 participants Est. completion 2019-12-30 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT03599466

    Clinical Bioequivalence Study on Two Lisinopril Tablets 20mg Formulations

    Not yet reported Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited 30 participants Est. completion 2020-04 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03629067

    Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

    Not yet reported Boryung Pharmaceutical Co., Ltd 60 participants Est. completion 2018-12-27 1 site Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Status unknown NCT NCT03658850

    Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients

    Not yet reported University of Sao Paulo 184 participants Est. completion 2020-03-10 1 site
    Other conditions: Hypernatremia, Critical Illness
    View official trial listing →
  • Completed NCT NCT03682692

    ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)

    Not yet reported Shanghai Jiao Tong University School of Medicine 560 participants Est. completion 2022-03-31 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT03720288

    Acetazolamide in Patients With Acute Heart Failure

    Not yet reported University of Sao Paulo General Hospital 90 participants Est. completion 2020-10-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT03889145

    A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide

    Not yet reported IlDong Pharmaceutical Co Ltd 30 participants Est. completion 2014-02-19 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03921736

    Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.

    Not yet reported Anna Posadzy-Małaczyńska 180 participants Est. completion 2005-11-17 Stand-alone
    Other conditions: Hypertension, Hyperuricemia, Menopause
    View official trial listing →
  • Status unknown NCT NCT03928145

    Efficacy of Chlorthalidone and Hydrochlorothiazide Combined With Amiloride on Blood Pressure in Primary Hypertension.

    Not yet reported Hospital de Clinicas de Porto Alegre 84 participants Est. completion 2021-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03946514

    Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients

    Not yet reported Shanghai Jiao Tong University School of Medicine 180 participants Est. completion 2024-08-31 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT03951558

    Comparison of the Impact of Diet vs Thiazide in BMD in Children With Idiopathic Hypercalciuria

    Not yet reported Hospital Infantil de Mexico Federico Gomez 90 participants Est. completion 2020-06-30 1 site Stand-alone
    Other conditions: Hypercalciuria; Idiopathic, Nephrolithiasis
    View official trial listing →
  • Completed NCT NCT03967496

    Assessment of Immediate Postoperative Delirium (IPD) in Adult Patients: Incidence and Etiologic Factors

    Sultan Qaboos University 402 participants Est. completion 2019-03-31 1 site
    Other conditions: Delirium, Anesthesia; Adverse Effect
    View official trial listing →
  • Completed NCT NCT03971929

    Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 36 participants Est. completion 2020-09-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT03978884

    Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes

    Not yet reported The University of The West Indies Est. completion 2020-12-31 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Hypertension
    View official trial listing →
  • Status unknown NCT NCT04103411

    Effect of High-Intensity Interval Training Compared to Hydrochlorothiazide on Ambulatory Blood Pressure

    Not yet reported Anil Nigam 60 participants Est. completion 2022-01-10 1 site Stand-alone
    Other conditions: Hypertension,Essential, Exercise Activity
    View official trial listing →
  • Status unknown NCT NCT04138888

    A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions

    Not yet reported Pharmtechnology LLC 32 participants Est. completion 2019-12-24 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Status unknown NCT NCT04182854

    Use of Diuretics in Maintenance Hemodialysis Patients Undergoing Bioimpedance-guided Fluid Management

    Not yet reported Capital Medical University 46 participants Est. completion 2021-07-01 1 site Stand-alone
    Other conditions: Diuretic Abuse
    View official trial listing →
  • Withdrawn NCT NCT04190433

    Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial

    Not yet reported Mayo Clinic Est. completion 2023-04-18 Stand-alone
    Other conditions: Breast Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm, Lymphoma, Sarcoma
    View official trial listing →
  • Status unknown NCT NCT04242758

    Phthalates Exposure in Type 2 Diabetic Patients and Diuretic Therapy

    Not yet reported University of Pisa 30 participants Est. completion 2020-04-01 1 site Stand-alone
    Other conditions: Renal Function Disorder, Glucose Metabolism Disorders
    View official trial listing →
  • Suspended NCT NCT04330300

    Coronavirus (COVID-19) ACEi/ARB Investigation

    Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
    Other conditions: Hypertension, COVID-19
    View official trial listing →
  • Completed NCT NCT04334824

    Hydrochlorothiazide and Risk of Skin Cancer

    Canadian Network for Observational Drug Effect Studies, CNODES 2953748 participants Est. completion 2021-03-05 1 site
    Other conditions: Non-melanoma Skin Cancer, Melanoma, Hypertension
    View official trial listing →
  • Completed NCT NCT04371874

    The Standardized Management of Hypertension in Rural Shaanxi

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 1210 participants Est. completion 2019-02 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT04423627

    Sympathetic Regulation of Large Artery Stiffness in Humans With ISH

    Not yet reported University of Iowa 100 participants Est. completion 2025-07-31 2 sites
    Other conditions: Hypertension, Systolic, Stiffness, Aortic
    View official trial listing →
  • Status unknown NCT NCT04465123

    Early Sequential Nephron Blockade in Acute Heart Failure Patients: A Randomised, Controlled Study

    Not yet reported Chiang Mai University 100 participants Est. completion 2022-12-31 1 site Stand-alone
    Heart failure Other conditions: Acute Kidney Injury
    View official trial listing →
  • Completed NCT NCT04467931

    ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

    University of Utah 22213 participants Est. completion 2020-12-31 1 site
    Other conditions: Hypertension, COVID
    View official trial listing →
  • Active, not recruiting NCT NCT04486118

    Centrally Acting ACE Inhibition in SLE

    Not yet reported Northwell Health 36 participants Est. completion 2026-03-01 7 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Active, not recruiting NCT NCT04550481

    Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

    Not yet reported Northwestern University 35 participants Est. completion 2026-09-30 4 sites Stand-alone
    MASH Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT04654312

    Study to Evaluate the Influence of Hydrochlorothiazide on Dermal Photosensitivity and DNA Stability - a Pilot Study (HCTox Study)

    Not yet reported Universität des Saarlandes 30 participants Est. completion 2021-07-22 1 site Stand-alone
    Other conditions: Photosensitivity
    View official trial listing →
  • Active, not recruiting NCT NCT04676399

    Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction

    Not yet reported University of Kansas Medical Center 36 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Chronic Pain, Hypertension, Diuretics Drug Reactions, SCS
    View official trial listing →
  • Completed NCT NCT04885660

    Bioequivalence Evaluation of Two Fixed-dose Combination of Lisinopril 10mg/Levamlodipine Besylate 5mg in Healthy Chinese Subjects

    Not yet reported The Affiliated Hospital of Qingdao University 92 participants Est. completion 2019-11-20 1 site Stand-alone
    Other conditions: Therapeutic Equivalency
    View official trial listing →
  • Completed NCT NCT04927299

    Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension

    Not yet reported Laboratorios Silanes S.A. de C.V. 163 participants Est. completion 2023-09-11 1 site
    Other conditions: Essential Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT04952051

    Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 1000 participants Est. completion 2020-07-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT04964050

    A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasting Conditions

    Not yet reported GlaxoSmithKline Est. completion 2022-05-26
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Withdrawn NCT NCT05016440

    Lisinopril for Renal Protection in Postpartum Preeclamptic Women

    Not yet reported Eastern Virginia Medical School Est. completion 2015-09-01 1 site
    Other conditions: Microalbuminuria, Preeclampsia
    View official trial listing →
  • Completed NCT NCT05040880

    A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers

    Not yet reported HK inno.N Corporation 46 participants Est. completion 2021-10-31 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT05049616

    Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension

    Not yet reported The University of Texas Health Science Center, Houston 70 participants Est. completion 2023-09-01 1 site Stand-alone
    Other conditions: Hypertension in Pregnancy, Postpartum Preeclampsia
    View official trial listing →
  • Completed NCT NCT05061901

    Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Conditions

    Not yet reported Pharmtechnology LLC 38 participants Est. completion 2021-11-06 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT05125224

    Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Dihydropyridine Calcium Channel Blockers Versus Hydrochlorothiazide

    Brigham and Women's Hospital 163720 participants Est. completion 2023-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT05443932

    Dapagliflozin and Hydrochlorothiazide in Recurring Kidney Stone Patients

    Not yet reported Medical University of Vienna 32 participants Est. completion 2025-12-31 1 site
    Other conditions: Urolithiasis, Hyperoxaluria
    View official trial listing →
  • Status unknown NCT NCT05545059

    Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 138 participants Est. completion 2023-03-31 1 site Stand-alone
    Other conditions: Resistant Hypertension
    View official trial listing →
  • Completed NCT NCT05609513

    Integration of Hypertension Management in HIV Care in Uganda

    Not yet reported Infectious Diseases Research Collaboration, Uganda 87421 participants Est. completion 2025-10-03 16 sites Stand-alone
    Other conditions: HIV/AIDS, Hypertension
    View official trial listing →
  • Completed NCT NCT05685277

    Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions

    Not yet reported Pharmtechnology LLC 50 participants Est. completion 2023-07-31 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Terminated NCT NCT05897372

    Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study

    Not yet reported Iain Bressendorff 1 participants Est. completion 2024-09-23 1 site Added to GLP-1
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT05917275

    Multi-Omics to Predict the Blood Pressure Response to Antihypertensives

    Not yet reported Radboud University Medical Center 96 participants Est. completion 2025-10 1 site Stand-alone
    Other conditions: Primary Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT06041529

    Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension

    Not yet reported Yuhan Corporation 198 participants Est. completion 2026-02-28 15 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT06083116

    Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 12 participants Est. completion 2019-10-10 1 site Stand-alone
    Other conditions: Diabetes in Adults
    View official trial listing →
  • Status unknown NCT NCT06187493

    Treatment of Patients With Diabetic Kidney Disease

    Not yet reported Assiut University 70 participants Est. completion 2025-12-31
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT06362668

    EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU)

    Not yet reported Reprieve Cardiovascular, Inc 12 participants Est. completion 2024-10-31 2 sites
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT06366386

    Integrating Hypertension Management in DSD for HIV

    Infectious Diseases Research Collaboration, Uganda 1100 participants Est. completion 2026-05-30 1 site
    Other conditions: Hypertension, HIV
    View official trial listing →
  • Completed NCT NCT06395194

    Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension

    Not yet reported Oslo University Hospital 15313 participants Est. completion 2003-12-05
    Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT06491940

    Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus Losartan

    Not yet reported RESnTEC, Institute of Research 234 participants Est. completion 2025-07-31 1 site Stand-alone
    Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT06681116

    Use of Nanotechnology Structured Water for the Prevention of Recurrent Stone Formation

    Not yet reported ALI KAMAL M. SAMI 325 participants Est. completion 2020-08-24 1 site Stand-alone
    Other conditions: Renal Stones, Idiopathic Hypercalciuria
    View official trial listing →
  • Completed NCT NCT06697353

    An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan

    Bayer 4936 participants Est. completion 2025-09-19 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT06772779

    A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026)

    Not yet reported Merck Sharp & Dohme LLC 36 participants Est. completion 2024-06-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT07177898

    ALLOPURINOL AND LISINOPRIL FOR DIABETIC KIDNEY PROTECTION: A COMPARATIVE STUDY IN NORMOURICEMIC TYPE 2 DIABETICS

    Not yet reported Narowal Medical College 80 participants Est. completion 2024-11-18 1 site
    Chronic kidney disease
    View official trial listing →
  • Not yet recruiting NCT NCT07262710

    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07469722

    POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure

    Not yet reported, Not yet reported Hospital de Clinicas de Porto Alegre 128 participants Est. completion 2028-07-01 1 site Stand-alone
    Heart failure Other conditions: Diuretic Effect, Lung Ultrasonography Score, Ultrasonography, Doppler, Point-of-care Ultrasound (POCUS)
    View official trial listing →
  • Completed NCT NCT07544888

    Effectiveness of Valsartan Alone vs Combination Therapy in Hypertensive Heart Disease

    Not yet reported Shaikh Zayed Hospital, Lahore 118 participants Est. completion 2026-03-01 1 site Stand-alone
    Other conditions: Heart Diseases, Hypertension
    View official trial listing →
  • Enrolling by invitation NCT NCT07547878

    Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

    Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Enrolling by invitation NCT NCT07568574

    Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

    Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 site Stand-alone
    Other conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
    View official trial listing →
  • Not yet recruiting NCT NCT07634068

    Vertebrobasilar Dolichoectasia Treatment With Amiloride

    Not yet reported Huashan Hospital 6 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Vertebrobasilar Dolichoectasia
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Hydrochlorothiazide, Lisinopril and Hydrochlorothiazide, Lisinopril

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.